Patents by Inventor Paul Patter

Paul Patter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of hydrosilylation catalysts
    Patent number: 11731115
    Abstract: A composition containing the following components: (a) a hydrosilylation catalyst comprising a metal-ligand complex, and (b) an inhibitor of the catalyst, wherein the inhibitor differs from the ligand of the metal-ligand complex and is represented by formula (I): X—CHR—CO—Y??(I), wherein —X represents —NO2, —S(?O)R, or Rc2RaC—CO—; Y represents 2-furyl, —S(?O)R, —CN, —NO2, or —CRbxRd3-x; Ra and Rb is independently selected from the group consisting of —O—R, —O—CO—R, —CO—O—R, 2-furyl, —S(?O)R, —CN, —NO2, —F, —Cl, and —Br; each of R is independently selected from the group consisting of —H, optionally fluorinated C1-C8-alkyl, —F, —Cl, and —Br; each of Rc and each of Rd is independently selected from the group consisting of —H, optionally fluorinated C1-C8-alkyl, —F, —Cl, and —Br; and x is 0 or 1.
    Type: Grant
    Filed: April 6, 2022
    Date of Patent: August 22, 2023
    Assignee: Joanneum Research Forschungsgesellschaft mbH
    Inventors: Krzysztof Krawczyk, Paul Patter
  • INHIBITORS OF HYDROSILYLATION CATALYSTS
    Publication number: 20220323945
    Abstract: A composition containing the following components: (a) a hydrosilylation catalyst comprising a metal-ligand complex, and (b) an inhibitor of the catalyst, wherein the inhibitor differs from the ligand of the metal-ligand complex and is represented by formula (I): X—CHR—CO—Y??(I), wherein —X represents —NO2, —S(?O)R, or Rc2RaC—CO—; Y represents 2-furyl, —S(?O)R, —CN, —NO2, or —CRbxRd3-x; Ra and Rb is independently selected from the group consisting of —O—R, —O—CO—R, —CO—O—R, 2-furyl, —S(?O)R, —CN, —NO2, —F, —Cl, and —Br; each of R is independently selected from the group consisting of —H, optionally fluorinated C1-C8-alkyl, —F, —Cl, and —Br; each of Rc and each of Rd is independently selected from the group consisting of —H, optionally fluorinated C1-C8-alkyl, —F, —Cl, and —Br; and x is 0 or 1.
    Type: Application
    Filed: April 6, 2022
    Publication date: October 13, 2022
    Applicant: Joanneum Research Forschungsgesellschaft mbH
    Inventors: Krzysztof Krawczyk, Paul Patter